Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1993 Sep;43(374):365–370.

Hormone replacement therapy: a study of women's knowledge and attitudes.

H K Sinclair 1, C M Bond 1, R J Taylor 1
PMCID: PMC1372520  PMID: 8251232

Abstract

Hormone replacement therapy can successfully treat menopausal symptoms. A postal questionnaire was used to investigate the knowledge of and attitudes to hormone replacement therapy of an age-stratified, computer-generated, representative sample of 1500 women living in the Grampian region of Scotland. A response rate of 78% was achieved. Comparisons were made between women of differing age, educational background and their current or past experience of hormone replacement therapy. The questionnaire also assessed their knowledge of osteoporosis, including the possible beneficial role of hormone replacement therapy. The results showed that women had a poor knowledge of the potential risks and benefits of oestrogen, lack of knowledge being greatest in the less educated and older women. The majority of women agreed with the view that because the menopause is brought on by diminished hormone levels, it should be viewed as a medical condition and treated as such, and also that a woman who experiences distressing menopausal symptoms should take hormone replacement therapy. Despite this, relatively few postmenopausal women were currently taking hormone replacement therapy (9%) or had taken the treatment in the past (7%), although many had experienced menopausal symptoms for over six months. The most common reason for postmenopausal women never having taken hormone replacement therapy was that they had never considered the treatment (70%) and had not discussed it with a doctor (79%).(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
368

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlow D. H., Grosset K. A., Hart H., Hart D. M. A study of the experience of Glasgow women in the climacteric years. Br J Obstet Gynaecol. 1989 Oct;96(10):1192–1197. doi: 10.1111/j.1471-0528.1989.tb03195.x. [DOI] [PubMed] [Google Scholar]
  2. Beaglehole R. Oestrogens and cardiovascular disease. BMJ. 1988 Sep 3;297(6648):571–572. doi: 10.1136/bmj.297.6648.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Christiansen C., Riis B. J. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. Br J Obstet Gynaecol. 1990 Dec;97(12):1087–1092. doi: 10.1111/j.1471-0528.1990.tb02495.x. [DOI] [PubMed] [Google Scholar]
  4. Cummings S. R., Browner W. S., Grady D., Ettinger B. Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? Ann Intern Med. 1990 Oct 15;113(8):565–567. doi: 10.7326/0003-4819-113-8-565. [DOI] [PubMed] [Google Scholar]
  5. Cummings S. R., Kelsey J. L., Nevitt M. C., O'Dowd K. J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178–208. doi: 10.1093/oxfordjournals.epirev.a036281. [DOI] [PubMed] [Google Scholar]
  6. Cust M. P., Gangar K. F., Hillard T. C., Whitehead M. I. A risk-benefit assessment of estrogen therapy in postmenopausal women. Drug Saf. 1990 Sep-Oct;5(5):345–358. doi: 10.2165/00002018-199005050-00004. [DOI] [PubMed] [Google Scholar]
  7. Egeland G. M., Kuller L. H., Matthews K. A., Kelsey S. F., Cauley J., Guzick D. Hormone replacement therapy and lipoprotein changes during early menopause. Obstet Gynecol. 1990 Nov;76(5 Pt 1):776–782. doi: 10.1097/00006250-199011000-00010. [DOI] [PubMed] [Google Scholar]
  8. Ferguson K. J., Hoegh C., Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Arch Intern Med. 1989 Jan;149(1):133–136. doi: 10.1001/archinte.149.1.133. [DOI] [PubMed] [Google Scholar]
  9. Gambrell R. D., Jr, Teran A. Z. Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy. Am J Obstet Gynecol. 1991 Aug;165(2):307–317. doi: 10.1016/0002-9378(91)90083-4. [DOI] [PubMed] [Google Scholar]
  10. Goldman L., Tosteson A. N. Uncertainty about postmenopausal estrogen. Time for action, not debate. N Engl J Med. 1991 Sep 12;325(11):800–802. doi: 10.1056/NEJM199109123251108. [DOI] [PubMed] [Google Scholar]
  11. Haarbo J., Hassager C., Jensen S. B., Riis B. J., Christiansen C. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am J Med. 1991 May;90(5):584–589. [PubMed] [Google Scholar]
  12. Hunt K. Perceived value of treatment among a group of long-term users of hormone replacement therapy. J R Coll Gen Pract. 1988 Sep;38(314):398–401. [PMC free article] [PubMed] [Google Scholar]
  13. Hunt K., Vessey M., McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol. 1990 Dec;97(12):1080–1086. doi: 10.1111/j.1471-0528.1990.tb02494.x. [DOI] [PubMed] [Google Scholar]
  14. Jensen G. F., Christiansen C., Boesen J., Hegedüs V., Transbøl I. Epidemiology of postmenopausal spinal and long bone fractures. A unifying approach to postmenopausal osteoporosis. Clin Orthop Relat Res. 1982 Jun;(166):75–81. [PubMed] [Google Scholar]
  15. Law M. R., Wald N. J., Meade T. W. Strategies for prevention of osteoporosis and hip fracture. BMJ. 1991 Aug 24;303(6800):453–459. doi: 10.1136/bmj.303.6800.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leiblum S. R., Swartzman L. C. Women's attitudes toward the menopause: an update. Maturitas. 1986 Mar;8(1):47–56. doi: 10.1016/0378-5122(86)90007-1. [DOI] [PubMed] [Google Scholar]
  17. Melton L. J., 3rd, Eddy D. M., Johnston C. C., Jr Screening for osteoporosis. Ann Intern Med. 1990 Apr 1;112(7):516–528. doi: 10.7326/0003-4819-112-7-516. [DOI] [PubMed] [Google Scholar]
  18. Purdie D. W. Broken bones--a gynaecological problem. Br J Obstet Gynaecol. 1988 Aug;95(8):737–739. doi: 10.1111/j.1471-0528.1988.tb06545.x. [DOI] [PubMed] [Google Scholar]
  19. Richelson L. S., Wahner H. W., Melton L. J., 3rd, Riggs B. L. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984 Nov 15;311(20):1273–1275. doi: 10.1056/NEJM198411153112002. [DOI] [PubMed] [Google Scholar]
  20. Rosenberg L., Hennekens C. H., Rosner B., Belanger C., Rothman K. J., Speizer F. E. Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol. 1981 Jan;139(1):47–51. doi: 10.1016/0002-9378(81)90410-5. [DOI] [PubMed] [Google Scholar]
  21. Sonnendecker E. W., Polakow E. S., Benadé A. J., Simchowitz E. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1128–1134. doi: 10.1016/0002-9378(89)90174-9. [DOI] [PubMed] [Google Scholar]
  22. Spector T. D. Use of oestrogen replacement therapy in high risk groups in the United Kingdom. BMJ. 1989 Dec 9;299(6713):1434–1435. doi: 10.1136/bmj.299.6713.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  24. Withholding of life-saving treatment. Lancet. 1990 Nov 3;336(8723):1121–1121. [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES